BNET Industries
Last Fiscal Year Sales:$17.5M
- Private
- US
Dow Jones Description
Personal support is our priority At Sperian Instrumentation, we pride ourselves on our high level of personal support. We recognize that in our business, quality support is as important to you as the products we offer. Our staff is friendly and expedient in all aspects of business because we really care about our customers. We recognize that in every business relationship at Sperian, people's lives may be at stake. We give each caller our complete attention.
Executive Vice President
Richard L. FossNumber of Employees 174
Peer Companies
NAICS Code Surgical Appliance and Supplies Manufacturing: 339113
Recent Events
-
WaferGen Biosystems to Introduce New Service for Gene-Expression Profiling Using the SmartChipTM Real-Time PCR System
News & Analysis
Filter by
biosystems and invitrogen corp. - All News and Analysis
Applied Biosystems Announces Internet Availability of Its 2008 Annual Report on Form 10-K
NORWALK, Conn. -- Applied Biosystems Inc. (NYSE: ABI) today announced the Internet availability of its 2008 Annual Report on Form 10-K. The Annual Report on Form 10-K has been filed with the U.S. Securities and Exchange Commission and may be accessed through the Company's investor relations website at http://ir.appliedbiosystems.com. Applied...
Applied Biosystems Sets Date for Special Meeting of Shareholders to Vote on Proposed Merger With Invitrogen Corporation
NORWALK, Conn. -- Applied Biosystems Inc. (NYSE:ABI) today announced it has set the date for a special meeting of its shareholders to consider the proposed merger with Invitrogen Corporation. The special meeting of shareholders will be held on October 16, 2008, at 9:30 a.m. EDT. Applied Biosystems shareholders of record...
Applied Biosystems to Webcast Presentation at the Piper Jaffray Europe Conference
FOSTER CITY, Calif. -- Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, will webcast its presentation at the Piper Jaffray Europe Conference in London on Wednesday, June 25, 2008. The live webcast is scheduled to begin at 9:40 a.m. GMT (4:40 a.m. EDT). Peter Dworkin, Vice President of Investor Relations...
Invitrogen and Applied Biosystems to Combine
Strategic Combination Creates Premier Provider of Biotechnology Reagents and Systems
Attractive Growth Projected in RNAi Market - Invitrogen and Applied Biosystems Revealed as Leading Suppliers in New Life Science Dashboard™ From Percepta Associates
CARLSBAD, Calif. -- Today Percepta Associates launched its Gene Silencing Life Science Dashboard[TM] market research report revealing market growth rates of between 11% and 30% for gene silencing methodologies. This new Dashboard presents key market indicators for the gene silencing market as a whole as well as for the following...
Zacks Analyst Interview Highlights: Fisher Scientific, Thermo Electron, Applied Biosystems, Waters Corp. and Invitrogen
CHICAGO -- Zacks.com releases the latest Analyst Interview. Today's interview is with equity research analyst Gregory Aurand, who discusses Fisher Scientific (NYSE:FSH), Thermo Electron (NYSE:TMO), Applied Biosystems (NYSE:ABI), Waters Corp. (NYSE:WAT) and Invitrogen (Nasdaq:IVGN).
Applied Biosystems Announces First Licensee Under Expanded PCR Licensing Program; Key Patents Covering Real-Time PCR Now Included in Program
FOSTER CITY, Calif. -- Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, today announced it has granted a license to Invitrogen Corp. (Nasdaq:IVGN) under the expanded Applied Biosystems PCR polymerase chain reaction licensing program. The expanded program includes patents for real-time PCR and other important PCR-related technology not licensed under...
Applied Biosystems announces strategic alliance with Invitrogen Corporation.
M2 PRESSWIRE-6 June 2005-US Financial Network: Applied Biosystems announces strategic alliance with Invitrogen CorporationC1994-2005 M2 COMMUNICATIONS LTD RDATE:06062005 City of Industry, CA - Biotechnology industry news provided by Financial News USA (OTC: FNWU). Applied Biosystems Group (NYSE: ABI), an Applera...
Invitrogen Corporation Expands Proteomics Capabilities with Launch of Mass Spectrometry Solutions and Co-Marketing Agreement with Applied Biosystems
SAN ANTONIO -- Invitrogen Corporation (Nasdaq:IVGN) today announced the availability of a suite of proteomics kits and reagents -- anchored by SILACTM protein identification and quantification labeling technology -- designed to help life scientists advance their proteomics research through the use of mass spectrometry. In concert, the company announced a...
Applied Biosystems and Invitrogen Corporation Form Strategic Alliance to Deliver Advanced Proteomic Solutions for Biomarker Discovery and Validation
FOSTER CITY, Calif. & SAN DIEGO -- Applied Biosystems Group (NYSE:ABI), an Applera Corporation business, and Invitrogen Corporation (NASDAQ:IVGN) today announced a strategic co-marketing and re-selling alliance to deliver solutions for proteomic analyses and biomarker studies in drug discovery and disease research worldwide.
- 1
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Richard L. Foss | Executive Vice President |
| Shan S. Sacranie | Executive Vice President |
| Jeff Brown | Senior Vice President and General Manager |
| Bill Sawka | Director of International Operations |
| Ray Rosati | Director of Engineering |
| Dave Macdonald | Quality Manager |
| Doug Hurne | Manufacturing Manager |
| Lars Boettern | Sales Manager |
| Trent Smith | National Product Sales Manager, Instrumentation |
| Arletta Greenwald | Divisional Controller |
| Cindi Lawrence | Controller |
| Jeff Emond | Senior Chemist |
| John Risinger | Staff Scientist |
| Larry Maxwell | Adjunct Investigator |
| Mateen Rizki | Associate Editor |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Jean-Yves Nothias | Board of Directors |
| John Patience | Board of Directors |
| L. John Wilkerson | Board of Directors |
| Richard T. Kogler | Board of Directors |
Richard L. Foss has served as Executive Vice President of Corporate Development since March 2003. Mr. Foss comes to Stericycle with a broad base of Healthcare and Marketing experience. He was most ...
| Organization | Position | Status |
|---|---|---|
| Biosystems | Executive Vice President | Current |
| Biosystems | Board of Directors | Current |
Shan S. Sacranie joined Stericycle as Executive Vice President, International in May, 2003. His prior assignments included that of President and Chief Executive for the Appliance Controls Group in ...
| Organization | Position | Status |
|---|---|---|
| Biosystems | Executive Vice President | Current |
| Biosystems | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Biosystems | Senior Vice President and General Manager | Current |
| Organization | Position | Status |
|---|---|---|
| Biosystems | Director of International Operations | Current |
| Biosystems | Marketing Manager | Former |
| Rensselaer Polytechnic Institute | Master's of Business Administration | Former |
| University of Hartford | Bachelor of Science Degree | Former |
| Organization | Position | Status |
|---|---|---|
| Biosystems | Director of Engineering | Current |
| Biosystems | Chemist | Former |
| Cornell University | Masters Degrees In Electrical Engineering | Former |
| Organization | Position | Status |
|---|---|---|
| Biosystems | Quality Manager | Current |
| Organization | Position | Status |
|---|---|---|
| Biosystems | Manufacturing Manager | Current |
| Technical College | Former |
| Organization | Position | Status |
|---|---|---|
| Biosystems | Sales Manager | Current |
| University of Pennsylvania | Former |
| Organization | Position | Status |
|---|---|---|
| Biosystems | National Product Sales Manager, Instrumentation | Current |
| Organization | Position | Status |
|---|---|---|
| Biosystems | Divisional Controller | Current |
| The Durham Manufacturing Company | Controller | Former |
| The Durham Manufacturing Company | Assistant Treasurer | Former |
| The Durham Manufacturing Company | Board of Directors | Former |
Cindi is a perfect example of an employee who has come up though the ranks. She started with Biosystems in 1987 as a receptionist. Cindi took advantage of the company's tuition reimbursement plan to receive her degree in Accounting (maintaining a 3.85 GPA while working full time) and moved to positions as bookeeper, assistant controller, and finally Chief Financial Officer. Besides making sure that the debits equal the credits, Cindi is responsible for the company's Personnel Department. Cindi's cash management skills and her lean and mean Accounting Department have been keys to the company's continued growth. Cindi's personal interests include auto racing, cooking, and a competitive game of poker.
| Organization | Position | Status |
|---|---|---|
| Biosystems | Controller | Current |
| Biosystems | receptionist | Former |
| Organization | Position | Status |
|---|---|---|
| Biosystems | Senior Chemist | Current |
| University of Connecticut | Master of Science degree in Polymer Chemistry | Former |
Dr. Risinger, Staff Scientist in the Laboratory of Biosystems and Cancer, provides mentorship and resources for fellows to complete a year of research training, including supervision, guidance, equipment and laboratory facilities.
| Organization | Position | Status |
|---|---|---|
| Biosystems | Staff Scientist | Current |
| Gynecologic Disease Center | Current |
Dr. Maxwell received his undergraduate degree with honors in chemistry and his medical degree with honors from the University of North Carolina. He completed his internship and residency with the military at William Beaumont Army Medical Center in El Paso, Tx. For his fellowship, he trained in the Division of Gynecologic Oncology at Duke University Medical Center. Dr. Maxwell is currently a board certified gynecologic oncologist and obstetrician gynecologist at Walter Reed Army Medical Center (WRAMC), where he serves as the Director of the Gynecologic Disease Center. He serves as a member of the Steering Committee for the Breast/Gynecologic Cancer Faculty at the National Cancer Institute (NCI) and also functions as an adjunct investigator in the Laboratory of Biosystems and Cancer at the NCI, where he pursues his basic science research activities, which have primarily involved identification of biomarkers associated with endometrial cancer. Dr. Maxwell has been the author and co-author of over 65 manuscripts and chapters. He has been recognized by the American College of Obstetricians with six awards at both the district and national level for his research. In 2001 and 2006, Dr. Maxwell received the Presidenta s Award for best paper and presentation at the annual clinical meeting of the Society of Clinical Oncology, and he is the only recipient to have received the award twice. His contributions to military medicine were recognized with the Surgeon General Recognition Award in 2002, which was given to only one medical officer at the rank of Major in the entire Army Medical Corps. Dr. Maxwell is the Director of Gynecologic Surgical Services for the NCI in a memorandum of understanding between the NCI and the U.S. Army that enables provision of gynecologic surgical care to patients on NCI Gynecologic protocols. Dr. Maxwella s clinical expertise in the field of thromboembolism prevention has also made him a frequent speaker at several medical centers and national meetings. He serves as the Deputy Director as well as Vice-Chair of the IRB for the United States Military Cancer Institute. Dr. Maxwell is also the Principal Investigator for several investigative groups.
| Organization | Position | Status |
|---|---|---|
| Biosystems | Adjunct Investigator | Current |
| Gynecologic Disease Center | Director | Current |
| The University of North Carolina | Undergraduate Degree With Honors In Chemistry | Former |
| Organization | Position | Status |
|---|---|---|
| Engineering Letters | Professor, Department of Computer Science and Engineering | Current |
| Biosystems | Associate Editor | Current |
| Spie | Board of Directors | Current |
| Ieee | Board of Directors | Current |
| Wayne State University | Lecturer | Former |
| Wright State University | Former | |
| Wayne State University | Ph.D. In Computer Science | Former |
| Wayne State University | M.S. Degree | Former |
| University of Michigan | B.S. Degree In Computer Science | Former |
| Organization | Position | Status |
|---|---|---|
| Scynexis, Inc. | Board of Directors | Current |
| Biosystems | Board of Directors | Current |
| Oddo & Cie | Analyst | Former |
| Hambrecht | Analyst | Former |
| Sorbonne University | Master's Degree In Management | Former |
John Patience has served as a director of the Company since its incorporation in March 1989. He is a co-founder and partner of Crabtree Partners, a private investment partnership in Lake Forest, Il...
| Organization | Position | Status |
|---|---|---|
| Biosystems | Board of Directors | Current |
L. John Wilkerson, Ph.D., has served as a director of the Company since July 1992. Dr. Wilkerson also serves as a general partner of Galen Partners, L.P. and Galen Partners International, L.P., aff...
| Organization | Position | Status |
|---|---|---|
| Biosystems | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Nnc Group | Executive Vice President, Chief Operating Officer | Current |
| Stericycle, Inc. | Coo | Current |
| Biosystems | Board of Directors | Current |
| Nnc Group | Board of Directors | Current |
| Stericycle, Inc. | Board of Directors | Current |
| Americ Corporation | Chief Operating Officer | Former |
| American Disposal | Chief Operating Officer | Former |
| American Disposal Services, Inc. | Chief Operating Officer | Former |
| Stericycle, Inc. | Executive Vice President | Former |
| Waste Management, Inc. | Vice President of Operations | Former |
| American Disposal Services, Inc. | Vice President | Former |
| Saint Louis University | B.A. Degree In Chemistry | Former |
Industry Transcripts by Seeking Alpha
-
Cantel Medical Corp. F1Q10 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 09, 2009about CMN
-
The Cooper Companies, Inc. F4Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Dec 08, 2009about COO
-
Medtronic Inc. F2Q10 (Qtr End 10/30/09) Earnings Call Transcript
on Nov 24, 2009about MDT
-
ZOLL Medical Corporation F4Q09 (Qtr End 27/09/09) Earnings Call Transcript
on Nov 11, 2009about ZOLL
-
RadNet, Inc. Q3 2009 Earnings Call Transcript
on Nov 09, 2009about RDNT


